AIMA
MDT icon

Ables Iannone Moore & Associates’s Medtronic MDT Stock Holding History

Ables Iannone Moore & Associates’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20
Closed -$1.65K – 191
2023
Q4 		$1.65K Buy
+20
New +$1.52K ﹤0.01% 234

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ables Iannone Moore & Associates's MDT Position: Q1 2024 in Review

Ables Iannone Moore & Associates sold out of Medtronic (MDT) in Q1 2024, closing a stake of 20 shares — an estimated $1.65K sold.

Ables Iannone Moore & Associates first reported a position in MDT in Q4 2023 and held it in 1 quarter. The position peaked at $1.65K in Q4 2023. 2,076 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

  • Ables Iannone Moore & Associates reported no remaining Medtronic position as of Q1 2024 after selling out during the quarter.
  • Ables Iannone Moore & Associates sold 20 Medtronic shares in Q1 2024, an estimated $1.65K.
  • Ables Iannone Moore & Associates first reported a position in Medtronic in Q4 2023 and held it in 1 quarter.
  • Ables Iannone Moore & Associates's Medtronic position peaked at $1.65K in Q4 2023.
  • 2,076 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on Ables Iannone Moore & Associates's 13F filing for Q1 2024, filed 30 Apr 2024.